|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
La Jolla Pharmaceutical Co (LJPC) |
|
|
$6.22 0.00 (0.00%) as of 4:30 Thu 8/18
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
27,470,000 |
| Market
Cap: |
170.86(M) |
| Last
Volume: |
2,592,323 |
Avg
Vol: |
2,585,089 |
| 52
Week Range: |
$6.22 - $6.22 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rolke James |
Chief Scientific Officer |
• – – |
2019-10-31 |
4 |
A |
$5.96 |
$793 |
D/D |
133 |
79,469 |
|
- |
|
| Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-10-31 |
4 |
A |
$5.96 |
$1,591 |
D/D |
267 |
3,217 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-10-31 |
4 |
A |
$5.96 |
$1,591 |
D/D |
267 |
4,490 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-10-31 |
4 |
A |
$5.96 |
$572 |
D/D |
96 |
6,594 |
|
- |
|
| Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-10-15 |
4 |
A |
$7.12 |
$1,595 |
D/D |
224 |
2,950 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-10-15 |
4 |
A |
$7.12 |
$577 |
D/D |
81 |
6,498 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-10-15 |
4 |
A |
$7.12 |
$797 |
D/D |
112 |
79,336 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-10-15 |
4 |
A |
$7.12 |
$1,595 |
D/D |
224 |
4,223 |
|
- |
|
| Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-09-30 |
4 |
A |
$7.48 |
$1,593 |
D/D |
213 |
2,726 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-09-30 |
4 |
A |
$7.48 |
$1,593 |
D/D |
213 |
3,999 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-09-30 |
4 |
A |
$7.48 |
$800 |
D/D |
107 |
79,224 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-09-30 |
4 |
A |
$7.48 |
$568 |
D/D |
76 |
6,417 |
|
- |
|
| Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-09-13 |
4 |
A |
$9.28 |
$1,587 |
D/D |
171 |
2,513 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-09-13 |
4 |
A |
$9.28 |
$789 |
D/D |
85 |
79,117 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-09-13 |
4 |
A |
$9.28 |
$1,587 |
D/D |
171 |
3,786 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-09-13 |
4 |
A |
$9.28 |
$575 |
D/D |
62 |
6,341 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-08-30 |
4 |
A |
$8.13 |
$569 |
D/D |
70 |
6,279 |
|
- |
|
| Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-08-30 |
4 |
A |
$8.13 |
$1,593 |
D/D |
196 |
2,342 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-08-30 |
4 |
A |
$8.13 |
$1,593 |
D/D |
196 |
3,615 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-08-30 |
4 |
A |
$8.13 |
$797 |
D/D |
98 |
79,032 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-08-15 |
4 |
A |
$8.02 |
$794 |
D/D |
99 |
78,934 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-08-15 |
4 |
A |
$8.02 |
$577 |
D/D |
72 |
6,209 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-08-15 |
4 |
A |
$8.02 |
$1,588 |
D/D |
198 |
3,419 |
|
- |
|
| Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-08-15 |
4 |
A |
$8.02 |
$1,588 |
D/D |
198 |
2,146 |
|
- |
|
| Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-07-31 |
4 |
A |
$7.11 |
$1,593 |
D/D |
224 |
1,948 |
|
- |
|
333 Records found
|
|
Page 7 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
